RESI (Redefining Early Stage Investments) seeks to bring together early stage life science companies with strategic investors in order to create solid funding opportunities. Lectenz Bio attended the conference to present their detection and analysis products. Learn more about RESI conferences here.
CEO Kausar Samli presents at #RESIBOS16 Innovation Challenge
Category: Lectenz Bio News
Date: September 13, 2016
Author: lectenz® Bio